Pathology of Malaria - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Pathology of Malaria

Description:

David P. Humber School of Biosciences University of East London Learning Outcomes Know the parasites, vector & epidemiology Understand of the life cycle Know the ... – PowerPoint PPT presentation

Number of Views:1059
Avg rating:3.0/5.0
Slides: 43
Provided by: homepage74
Category:

less

Transcript and Presenter's Notes

Title: Pathology of Malaria


1
Pathology of Malaria
  • David P. Humber
  • School of Biosciences
  • University of East London

2
Learning Outcomes
  • Know the parasites, vector epidemiology
  • Understand of the life cycle
  • Know the principal clinical features and
    pathology and the basis of diagnosis
  • Appreciate the difficulties of control

3
The Problem
  • At Risk
  • More than 40 of the world population
  • Deaths
  • More than 2 million per year
  • Chemotherapy
  • Limited Drugs drug resistance
  • Vector control
  • Vaccination

4
The Parasite - Taxonomy
  • Phylum - Apicomplexa (Sporozoa)
  • Class - Haemosporidea (Sporozoea)
  • Order - Haemosporidia
  • Genus - Plasmodium

5
Species Infecting Humans
  • Common Severe
  • Rare Mild
  • Plasmodium falciparum
  • Malignant tertian (Cerebral)
  • Plasmodium vivax
  • Tertian
  • Plasmodium ovale
  • Tertian
  • Plasmodium malariae
  • Quartan

6
Species Infecting Humans
  • Relapses Fevers
  • No 24-48
  • Yes 48
  • Yes 48
  • No 72
  • Rare Mild
  • Plasmodium falciparum
  • Tropical Africa, Asia, Latin America
  • Plasmodium vivax
  • Worldwide
  • Plasmodium ovale
  • Tropical West Africa
  • Plasmodium malariae
  • Worldwide but very patchy

7
Epidemiology
  • gt400 million cases annually
  • 3 million deaths
  • majority 2-5 years
  • 103 endemic countries
  • most in Africa
  • most due to P.falicparum
  • Need 15oCfor 4 weeks lt300m
  • 64oN to 32oS

8
Distribution of Malaria
9
Life Cycle
Liver Schizont
Sporozoite
Trophozoite
Oocyst
RBC
Merozoite
Ookinete
Gametocytes
10
Infected Liver CellHepatocyte
Pre-erythrocytic schizonts
11
Erythrocytic forms (signet)
Young ring form trophozoites
12
Gametocytes
P.falciparum
Macro
Micro
13
Exflagellation
P. vivax produces 8 microgamentes in mosquitos
midgut
14
Clinical Features
  • Pre-patent Period
  • Time taken from infection to symptoms
  • P. falciparum 6-12 days
  • P. vivax 10-17days
  • P ovale 14 days
  • P. malariae 28-30 days

15
Clinical Features of Malaria
  • Cold stage ???hr
  • Headache/shiver/rapid weak pulse
  • Hot stage 6hrs
  • Intense headache/nausea/thirst/distress
  • Sweating stage 4hrs
  • Profuse sweating
  • Sleep!
  • Prepatent period
  • Flu-like initially
  • Intermittent fever
  • Recurrence
  • Coma/death
  • Chronic infection
  • Relapses

16
Tertian Malaria - P. vivax P. ovale
  • Rarely fatal- relapses common
  • Prodrome
  • myalgia, headache, chilliness, low grade
    irregular fever (no sync maturation cycle)
  • Synchronisation _at_ 5-7 days - paroxysms on
    alternate days
  • Spleen palpable 10-14 days
  • P. ovale milder with shorter initial attacks

17
Qartan Malaria - P. malariae
  • Paroxysms every third day
  • Mildest and most chronic of the 4
  • immune complex nephropathy
  • seasonal variation with P.f (wet season)

18
Falciparum Malaria
  • Cause of virtually all malaria deaths
  • asynchronous cycle
  • onset insidious - fever variable
  • Rapid onset of splenomegaly
  • Severe anaemia, jaundice, hyperventilation, cns
    dysfunction (delirium, stupor, coma) . . . . . .
    . . .

19
Fever Charts
20
Untreated P. falciparum malaria
  • Sequestration - (schizogony completed)
  • Bind to endothelia cells surface receptors eg
    ICAM1 - via membrane knobs with histidine rich
    protein
  • Reduced in some individuals - splenectomy
    genetic background
  • Clumping also occurs (platelets involved?)

21
Site Specific Sequestration
  • Brain
  • measurable reduction in blood flow
  • Intestines
  • diarrhoea
  • Placenta
  • intervillus space

22
Hepatosplenomegaly
  • Hepatic dysfunction
  • Hyperplasia of splenic/liver macrophages
  • Normally transient
  • related to parasite load
  • Tropical splenomegally
  • Proportion of adult develop very large spleens
  • Genotype/IR genes

23
Hepato-splenomegaly
10-15 die - survivors partially immune often
with splenomegaly
24
Cerebral Malaria
  • Coma 6- 96 hours
  • shorter in children
  • 20 fatality
  • Hepatoslenomegaly common
  • Retinal haemorrhages

25
Cerebral Malaria
Numerous small haemorrhages of grey matter
26
Brain section - P. falciparum
27
Nephrosis
  • Renal failure common in adults
  • poor prognosis
  • Transient Nephrosis
  • all species
  • Nephrotic Syndrome
  • P. malariae - IC mediated

28
Nephrosis
P. Malariae quarten nephrosis
29
Blackwater Fever
  • Massive intra vascular haemolysis
  • haemoglobinuria
  • acute renal failure
  • tubule necrosis
  • parasitemia may be absent
  • nonimmune or G6PD deficiency treatment -
    autoimmuninty?
  • Mortality 20-30

30
Pregnancy
  • Serious complication in pregnancy
  • maternal deaths, foetal death (x10) foetal
    retardation
  • Placental sequestration clumping
  • accumulation of intervillus macrophages fibrin
    deposits

31
Section of Placenta
32
Diagnosis
  • Clinical symptoms
  • Regular fevers / possible exposure
  • Stained fixed blood smear
  • Thick film - presence/absence
  • Thin film - morphology/species
  • Blood
  • Capillary - fluorescence
  • Antigen capture
  • PCR/Mabs

33
Chemotherapy
  • Quinine
  • Extract of tree bark
  • used since 17th century
  • 1.3 - 2.0g/day for 7 -10 days
  • Tonic water!
  • Methylene blue
  • pamaquine
  • mepacrine

34
Synthetic antmalarials
  • Chloroquine
  • Developed by Bayer in 1934 (toxic!)
  • Rediscoved in the mid 1940s
  • selective uptake by food vacuole
  • intefers with haem polymersiation/detox reactive
    oxygen species
  • Resistance in humans early 1960s

35
Other Antimalarials
  • Proguanil - 1948
  • Primaquine - 1951
  • Pyrimethamine - 1952
  • Cycloquanil - 1963

Resistant strains by late 1960s
36
Treatment v Prophylaxis
  • Monotherapy
  • Treatment
  • high dose short term
  • Prophylaxis
  • low dose long term

37
Immune Mechanisms
  • Antibody blocks merozoite infection of RBCs
  • passive transfer experiment in the Gambia
  • Enhance clearance through opsonisation
  • ADCC likely
  • NK activity
  • Decrease in circulating T cells
  • Down regulation of T cell function
  • Spleen - spleenectomy!

38
Cytokines
  • IL1
  • TNF
  • IL10

39
Stage specific
  • Anti sporozoite antibodies in adults in endemic
    areas- blocks liver invasion
  • Anti sporozoite/merozoite antibodies - block rbc
    invasion
  • TNF blocks merozoite development
  • Erythrocyte clearance - liver and spleen
  • Block cyto-adherence

40
Immunomodulation
  • Poly clonal T B activation
  • auto antibodies - anaemia?
  • Immunodepression
  • humoral cellular - T, B macrophage

41
Immunopathology
  • Fever
  • correlates with schizont rupture
  • IL1 TNF
  • Anaemia
  • common complication exceeds parasitemia may
    worsen after treatment
  • T cell control of spllenomegally/bone marrow

42
Immunopathology 2
  • Cerebral malaria
  • highly reversible
  • Under T cell control - IL1/TNF
  • Glomerulonephritis
  • Not very common - acute nephritis reversed by
    treatment
  • IgM, IgG C3 - autoimmune?
  • treatment mediated
Write a Comment
User Comments (0)
About PowerShow.com